|
93 Companies |
|
118 Products |
|
118 Products |
|
88 Mechanisms of Action |
|
3 Trials |
|
1622 News |
|
| «12...56789101112131415...3233» |
- |||| morphine sulphate / Generic mfg.
Trial completion: Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management (clinicaltrials.gov) - Mar 18, 2015
P4, N=1645, Completed, Sponsor: Hamad Medical Corporation
Recruiting --> Completed
- ||| Trial completion: HMO-VOL: The Effects Of HMO On The Faecal Microbiota And On Gastrointestinal Symptoms In Healthy Volunteers (clinicaltrials.gov) - Mar 18, 2015
P=N/A, N=100, Completed, Sponsor: Glycom A/S
Recruiting --> Completed Not yet recruiting --> Completed
- Trial primary completion date: Effects of Self-administered Acupressure in Psychiatric Patients With Constipation (clinicaltrials.gov) - Mar 14, 2015
P1/2, N=78, Active, not recruiting, Sponsor: The Hong Kong Polytechnic University
Not yet recruiting --> Completed Trial primary completion date: Apr 2014 --> Aug 2015
- ||||| Ibodutant (MEN 15596) / Menarini
Trial initiation date: IRIS-05: 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) (clinicaltrials.gov) - Mar 14, 2015
P3, N=500, Not yet recruiting, Sponsor: Menarini Group
Trial primary completion date: Apr 2014 --> Aug 2015 Initiation date: Oct 2014 --> Oct 2015
- |||| Trial completion: Managing Medication-induced Constipation in Cancer: A Clinical Trial (clinicaltrials.gov) - Mar 14, 2015
P1/2, N=601, Completed, Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Initiation date: Oct 2014 --> Oct 2015 Active, not recruiting --> Completed
- ondansetron intravenous / Generic mfg., dexamethasone injection / Generic mfg., palonosetron intravenous / Generic mfg.
Trial primary completion date: Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients (clinicaltrials.gov) - Mar 12, 2015
P2, N=85, Recruiting, Sponsor: Northside Hospital, Inc.
Active, not recruiting --> Completed Trial primary completion date: Jun 2015 --> Sep 2015
- Enrollment closed, Trial primary completion date: Mechanism of Action of Biofeedback Therapy (clinicaltrials.gov) - Mar 11, 2015
P2, N=50, Active, not recruiting, Sponsor: Georgia Regents University
Trial primary completion date: Jun 2015 --> Sep 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Dec 2015
- Trial completion, Trial primary completion date: Therapeutic Effects of Neurofeedback in Anorexia Nervosa (clinicaltrials.gov) - Mar 11, 2015
P1/2, N=12, Completed, Sponsor: Medical University of Graz
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Dec 2015 Active, not recruiting --> Completed | Trial primary completion date: May 2014 --> Nov 2014
- Trial primary completion date: Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer (clinicaltrials.gov) - Mar 10, 2015
P2/3, N=745, Completed, Sponsor: Gary Morrow
Active, not recruiting --> Completed | Trial primary completion date: May 2014 --> Nov 2014 Trial primary completion date: Dec 2008 --> Aug 2011
- | miglustat / Generic mfg.
Trial completion: Two Period / Two Treatment Cross-over to Assess the Effect of Florastor (clinicaltrials.gov) - Mar 10, 2015
P1, N=42, Completed, Sponsor: Actelion
Trial primary completion date: Dec 2008 --> Aug 2011 Active, not recruiting --> Completed
- || RotaTeq (Live attenuated pentavalent Rotavirus oral vaccine) / Merck (MSD)
Trial primary completion date: An Alternate Dosing Schedule for Pentavalent Rotavirus Vaccine (RotaTeq) (clinicaltrials.gov) - Mar 7, 2015
P4, N=60, Recruiting, Sponsor: Emmanuel Walter
Active, not recruiting --> Completed Trial primary completion date: May 2015 --> Aug 2015
- | relamorelin (RM-131) / AbbVie
Enrollment closed, P2 data: Phase 2 Pilot Study to Evaluate the Safety and Efficacy of RM-131 Administered to Females With Anorexia Nervosa (clinicaltrials.gov) - Mar 7, 2015
P2, N=20, Active, not recruiting, Sponsor: Rhythm Pharmaceuticals, Inc.
Trial primary completion date: May 2015 --> Aug 2015 Recruiting --> Active, not recruiting
- Enrollment open: Use of Novel Prebiotic Fiber for Targeted Dietary Management of Irritable Bowel Syndrome (Nutrabiotix Phase II) (clinicaltrials.gov) - Mar 7, 2015
P2, N=120, Recruiting, Sponsor: Nutrabiotix, LLC
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | relamorelin (RM-131) / AbbVie
Trial completion: Study to Evaluate the Effects of RM-131 in Patients With Chronic Constipation (clinicaltrials.gov) - Mar 7, 2015
P1, N=18, Completed, Sponsor: Rhythm Pharmaceuticals, Inc.
Not yet recruiting --> Recruiting Recruiting --> Completed
- Amitiza (lubiprostone) / Takeda, Mallinckrodt
Enrollment change: Effect of Lubiprostone on Nutritional Status and Pulmonary Function in Adults With Cystic Fibrosis (clinicaltrials.gov) - Mar 5, 2015
P=N/A, N=7, Terminated, Sponsor: University of Arkansas
Recruiting --> Completed N=15 --> 7
- ||||||| Trial completion: A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea (clinicaltrials.gov) - Mar 4, 2015
P3, N=520, Completed, Sponsor: Genzyme, a Sanofi Company
N=15 --> 7 No longer recruiting --> Completed
- Enrollment open, Trial primary completion date: Body Image Therapy in Anorexia Nervosa (clinicaltrials.gov) - Mar 2, 2015
P=N/A, N=100, Recruiting, Sponsor: Centre Hospitalier St Anne
No longer recruiting --> Completed Not yet recruiting --> Recruiting | Trial primary completion date: Feb 2014 --> Oct 2015
- Trial completion, Enrollment change: Narcisse: "Self-consciousness and the Inter-subjective Body" (clinicaltrials.gov) - Mar 2, 2015
P=N/A, N=39, Completed, Sponsor: Centre Hospitalier St Anne
Not yet recruiting --> Recruiting | Trial primary completion date: Feb 2014 --> Oct 2015 Not yet recruiting --> Completed | N=100 --> 39
- esmolol / Generic mfg.
Enrollment status, Trial primary completion date, Surgery: Effect of Lidocaine and Esmolol to Improve the Quality of Recovery (clinicaltrials.gov) - Mar 2, 2015
P4, N=192, Recruiting, Sponsor: Cedars-Sinai Medical Center
Not yet recruiting --> Completed | N=100 --> 39 Enrolling by invitation --> Recruiting | Trial primary completion date: Feb 2014 --> Feb 2015
- || Enrollment closed: Bihar Evaluation of Social Franchising and Telemedicine (clinicaltrials.gov) - Feb 27, 2015
P=N/A, N=106380, Active, not recruiting, Sponsor: Duke University
Enrolling by invitation --> Recruiting | Trial primary completion date: Feb 2014 --> Feb 2015 Enrolling by invitation --> Active, not recruiting
- Trial completion, Enrollment change, Trial primary completion date, Compliance: Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia (clinicaltrials.gov) - Feb 23, 2015
P4, N=262, Completed, Sponsor: RenJi Hospital
Enrolling by invitation --> Active, not recruiting Recruiting --> Completed | N=400 --> 262 | Trial primary completion date: Sep 2013 --> Jun 2014
- Trial primary completion date: The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa (clinicaltrials.gov) - Feb 19, 2015
P2, N=30, Recruiting, Sponsor: Massachusetts General Hospital
Recruiting --> Completed | N=400 --> 262 | Trial primary completion date: Sep 2013 --> Jun 2014 Trial primary completion date: Jun 2015 --> Dec 2015
- || Trial initiation date, Trial primary completion date: LACTINEDAP: Limited Abdominal CT in ED Patients With Abdominal Pain (clinicaltrials.gov) - Feb 19, 2015
P=N/A, N=1000, Not yet recruiting, Sponsor: Duke University
Trial primary completion date: Jun 2015 --> Dec 2015 Initiation date: May 2014 --> May 2015 | Trial primary completion date: Sep 2015 --> May 2018
- |||||| Barhemsys (intravenous amisulpride) / Acacia Pharma
Enrollment open: Phase IIIb Study of APD421 in Combination as PONV Prophylaxis (clinicaltrials.gov) - Feb 19, 2015
P3, N=1100, Recruiting, Sponsor: Acacia Pharma Ltd
Initiation date: May 2014 --> May 2015 | Trial primary completion date: Sep 2015 --> May 2018 Not yet recruiting --> Recruiting
- ||| Trial completion, Enrollment change: Evaluating the Impact of Community Led Total Sanitation Programs in Mali (clinicaltrials.gov) - Feb 19, 2015
P=N/A, N=39246, Completed, Sponsor: Universidad Nacional de La Plata
Not yet recruiting --> Recruiting Active, not recruiting --> Completed | N=24000 --> 39246
- ||||| Symproic (naldemedine) / Shionogi, Collegium Pharma
Enrollment closed: Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation (clinicaltrials.gov) - Feb 19, 2015
P3, N=540, Active, not recruiting, Sponsor: Shionogi
Active, not recruiting --> Completed | N=24000 --> 39246 Recruiting --> Active, not recruiting
- ||||| Symproic (naldemedine) / Shionogi, Collegium Pharma
Enrollment closed: Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation (clinicaltrials.gov) - Feb 19, 2015
P3, N=540, Active, not recruiting, Sponsor: Shionogi
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- ||||| Symproic (naldemedine) / Shionogi, Collegium Pharma
Enrollment closed: Long Term Safety of Naldemedine (clinicaltrials.gov) - Feb 19, 2015
P3, N=1500, Active, not recruiting, Sponsor: Shionogi
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Trial completion, Trial primary completion date: PROBAGE: Effects of Probiotics and/or Prebiotics on the Duration of Diarrhea and Hospitalization in Children (clinicaltrials.gov) - Feb 19, 2015
P4, N=1280, Completed, Sponsor: Eskisehir Osmangazi University
Recruiting --> Active, not recruiting Recruiting --> Completed | Trial primary completion date: Aug 2013 --> Jan 2015
- ||| Trial completion: Survey of Prevalence of Loss of Appetite in Subject With Health Disorders (clinicaltrials.gov) - Feb 11, 2015
P=N/A, N=16629, Completed, Sponsor: Bayer
Recruiting --> Completed | Trial primary completion date: Aug 2013 --> Jan 2015 Active, not recruiting --> Completed
- || Trial primary completion date: Efficacy Study of Ginger (Zingiber Officinale) Extract "Ginpax" to Manage Nausea in Cancer Patients Receiving High Emetogenic Treatments and Standard Anti-emetogenic Therapy (clinicaltrials.gov) - Feb 11, 2015
P=N/A, N=250, Recruiting, Sponsor: Helsinn Healthcare SA
Active, not recruiting --> Completed Trial primary completion date: Aug 2014 --> Feb 2015
- morphine sulphate / Generic mfg., ropivacaine / Generic mfg.
Surgery: GR-CWI: Continuous Local Anesthetic and Steroid Infusion in Abdominal Surgery (clinicaltrials.gov) - Feb 10, 2015
P3, N=120, Recruiting, Sponsor: IRCCS Policlinico S. Matteo
Trial primary completion date: Aug 2014 --> Feb 2015 Trial primary completion date: Apr 2014 --> Apr 2016
- ||||| Linzess (linaclotide) / Astellas, Ironwood Pharma, AbbVie
Enrollment closed: A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) (clinicaltrials.gov) - Feb 6, 2015
P3, N=800, Active, not recruiting, Sponsor: AstraZeneca
Trial primary completion date: Apr 2014 --> Apr 2016 Recruiting --> Active, not recruiting
- Trial termination, Trial primary completion date: Enteral Naloxone Versus a Traditional Bowel Regimen for the Prevention of Opioid Induced Constipation in Trauma Patients (clinicaltrials.gov) - Feb 5, 2015
P4, N=3, Terminated, Sponsor: CAMC Health System
Recruiting --> Active, not recruiting Active, not recruiting --> Terminated | Trial primary completion date: Aug 2014 --> Oct 2012; Naloxone became unavailable due to manufacturing shortatges requiring the study to be terminated.
- bevenopran (CB-5945) / Eli Lilly, Merck (MSD)
Trial primary completion date: The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation (clinicaltrials.gov) - Feb 5, 2015
P3, N=44, Terminated, Sponsor: Cubist Pharmaceuticals
Active, not recruiting --> Terminated | Trial primary completion date: Aug 2014 --> Oct 2012; Naloxone became unavailable due to manufacturing shortatges requiring the study to be terminated. Trial primary completion date: Mar 2015 --> Feb 2014
- bevenopran (CB-5945) / Eli Lilly, Merck (MSD)
Trial primary completion date: Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation (clinicaltrials.gov) - Feb 5, 2015
P3, N=49, Terminated, Sponsor: Cubist Pharmaceuticals
Trial primary completion date: Mar 2015 --> Feb 2014 Trial primary completion date: Mar 2015 --> Feb 2014
- bevenopran (CB-5945) / Eli Lilly, Merck (MSD)
Trial primary completion date: Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation (clinicaltrials.gov) - Feb 5, 2015
P3, N=61, Terminated, Sponsor: Cubist Pharmaceuticals
Trial primary completion date: Mar 2015 --> Feb 2014 Trial primary completion date: Mar 2015 --> Jan 2014
- bevenopran (CB-5945) / Eli Lilly, Merck (MSD)
Trial primary completion date: Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation (clinicaltrials.gov) - Feb 5, 2015
P3, N=1407, Terminated, Sponsor: Cubist Pharmaceuticals
Trial primary completion date: Mar 2015 --> Jan 2014 Trial primary completion date: Dec 2014 --> Jun 2014
- Emend intravenous (fosaprepitant) / Merck (MSD), Ono Pharma
Trial primary completion date: Fosaprepitant in Patients Receiving Ifosfamide-based Regimen (clinicaltrials.gov) - Feb 5, 2015
P=N/A, N=40, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Dec 2014 --> Jun 2014 Trial primary completion date: May 2015 --> May 2016
- ||| Trial completion: Impact of Bismuth Subsalicylate on Antimicrobial Use Among Adult Diarrhea Outpatients--Pakistan (clinicaltrials.gov) - Feb 5, 2015
P=N/A, N=400, Completed, Sponsor: Centers for Disease Control and Prevention
Trial primary completion date: May 2015 --> May 2016 Not yet recruiting --> Completed
- omeprazole / Generic mfg.
Enrollment open, Enrollment change, Trial initiation date, Trial primary completion date: Use of Maytenus Ilicifolia in the Treatment of Dyspepsia (clinicaltrials.gov) - Feb 3, 2015
P2, N=140, Recruiting, Sponsor: Casa Espirita Terra de Ismael
Not yet recruiting --> Completed Not yet recruiting --> Recruiting | N=20 --> 140 | Initiation date: Sep 2011 --> Feb 2015 | Trial primary completion date: Aug 2012 --> Feb 2016
- esomeprazole / Generic mfg.
Trial primary completion date: BRAVO Study for Functional Dyspepsia (clinicaltrials.gov) - Feb 3, 2015
P4, N=130, Recruiting, Sponsor: Chinese University of Hong Kong
Not yet recruiting --> Recruiting | N=20 --> 140 | Initiation date: Sep 2011 --> Feb 2015 | Trial primary completion date: Aug 2012 --> Feb 2016 Trial primary completion date: Dec 2014 --> Dec 2015
- Cesamet (nabilone) / Bausch Health, Viatris
Enrollment open, Surgery: Study of Prevention of Postoperative Nausea and Vomiting Using Cesamet (clinicaltrials.gov) - Feb 2, 2015
P2, N=330, Recruiting, Sponsor: St. Michael's Hospital, Toronto
Trial primary completion date: Dec 2014 --> Dec 2015 Not yet recruiting --> Recruiting
- ||| dexmedetomidine / Generic mfg.
Surgery: Effects of a Dexmedetomidine on Quality of Recovery 40 and Postoperative Nausea and Vomiting in Breast Cancer Surgery (clinicaltrials.gov) - Feb 2, 2015
P=N/A, N=97, Completed, Sponsor: Yonsei University
Not yet recruiting --> Recruiting Recruiting --> Completed | Trial primary completion date: Jan 2012 --> Jul 2012
- ||||| Trial initiation date, Trial primary completion date: Efficacy and Safety of Polyethylene Glycol 3350 (PEG 3350) for Relief of Constipation (MK-8114-005) (clinicaltrials.gov) - Jan 30, 2015
P3, N=120, Not yet recruiting, Sponsor: Merck Sharp & Dohme Corp.
Recruiting --> Completed | Trial primary completion date: Jan 2012 --> Jul 2012 Initiation date: Nov 2014 --> Dec 2015 | Trial primary completion date: Dec 2014 --> Dec 2015
- Trial completion, Enrollment change: Inpatient Exposure Therapy and Response Prevention & Cognitive Remediation Therapy for Anorexia Nervosa (clinicaltrials.gov) - Jan 29, 2015
P=N/A, N=40, Completed, Sponsor: New York State Psychiatric Institute
Initiation date: Nov 2014 --> Dec 2015 | Trial primary completion date: Dec 2014 --> Dec 2015 Active, not recruiting --> Completed | N=30 --> 40
- |||| Trial completion: A Study to Demonstrate the Efficacy and Safety of Motilitone® (clinicaltrials.gov) - Jan 28, 2015
P4, N=389, Completed, Sponsor: Dong-A ST Co., Ltd.
Active, not recruiting --> Completed | N=30 --> 40 Recruiting --> Completed
- || ondansetron / Generic mfg.
Trial primary completion date: AVERT: Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal Radiotherapy (clinicaltrials.gov) - Jan 26, 2015
P2, N=61, Recruiting, Sponsor: University of Vermont
Recruiting --> Completed Trial primary completion date: Jun 2014 --> Jun 2015
- relamorelin (RM-131) / AbbVie
P2 data, Trial primary completion date: Phase 2 Pilot Study to Evaluate the Safety and Efficacy of RM-131 Administered to Females With Anorexia Nervosa (clinicaltrials.gov) - Jan 22, 2015
P2, N=20, Recruiting, Sponsor: Rhythm Pharmaceuticals, Inc.
Trial primary completion date: Jun 2014 --> Jun 2015 Trial primary completion date: Dec 2014 --> Mar 2015
- mizagliflozin (VGX-3235) / Vogenx
New P2 trial: Phase II Study of KWA-0711 in Patients With Chronic Constipation (CC) (clinicaltrials.gov) - Jan 22, 2015
P2, N=0, Recruiting, Sponsor: Kissei Pharmaceutical Co., Ltd.